BR0212013A - Fosfatos micronutrientes como suplementos dietéticos ou para a saúde - Google Patents

Fosfatos micronutrientes como suplementos dietéticos ou para a saúde

Info

Publication number
BR0212013A
BR0212013A BR0212013-5A BR0212013A BR0212013A BR 0212013 A BR0212013 A BR 0212013A BR 0212013 A BR0212013 A BR 0212013A BR 0212013 A BR0212013 A BR 0212013A
Authority
BR
Brazil
Prior art keywords
dietary
micronutrient
phosphates
health supplements
health
Prior art date
Application number
BR0212013-5A
Other languages
English (en)
Inventor
Simon Michael West
David Kannar
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Publication of BR0212013A publication Critical patent/BR0212013A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Grain Derivatives (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"FOSFATOS MICRONUTRIENTES COMO SUPLEMENTOS DIETéTICOS OU PARA A SAúDE". Trata-se de um suplemento dietético ou para a saúde que compreende uma quantidade eficaz de um micronutriente selecionado do grupo que consiste em derivados de fosfato de tocoferol, ubiquinol, ácido ascórbico, tocotrienol, retinol e as suas misturas aplicadas com um veículo aceitável.
BR0212013-5A 2001-08-06 2002-08-06 Fosfatos micronutrientes como suplementos dietéticos ou para a saúde BR0212013A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR6848A AUPR684801A0 (en) 2001-08-06 2001-08-06 Supplement therapy
PCT/AU2002/001081 WO2003013550A1 (en) 2001-08-06 2002-08-06 Micronutrient phosphates as dietary and health supplements

Publications (1)

Publication Number Publication Date
BR0212013A true BR0212013A (pt) 2004-08-03

Family

ID=3830804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212013-5A BR0212013A (pt) 2001-08-06 2002-08-06 Fosfatos micronutrientes como suplementos dietéticos ou para a saúde

Country Status (12)

Country Link
US (2) US20050009787A1 (pt)
EP (1) EP1414470B1 (pt)
JP (1) JP2005506972A (pt)
AT (1) ATE357919T1 (pt)
AU (1) AUPR684801A0 (pt)
BR (1) BR0212013A (pt)
CA (1) CA2453884A1 (pt)
DE (1) DE60219174T2 (pt)
ES (1) ES2284900T3 (pt)
MX (1) MXPA04000819A (pt)
WO (1) WO2003013550A1 (pt)
ZA (1) ZA200400187B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
MXPA04000654A (es) * 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
EP2269650A3 (en) * 2004-08-03 2012-05-16 Vital Health Sciences Pty Ltd. Carrier for enteral administration
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
NZ565049A (en) * 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
EP2531047A4 (en) 2010-02-05 2014-03-19 Phosphagenics Ltd CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE
EP2531219A4 (en) * 2010-02-05 2015-01-14 Phosphagenics Ltd SUPPORT COMPOSITION
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
JP5868591B2 (ja) * 2010-12-24 2016-02-24 日清オイリオグループ株式会社 製菓製パン用油脂組成物
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
AU2017381395A1 (en) 2016-12-21 2019-06-20 Phosphagenics Limited Process

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2667479A (en) * 1951-01-30 1954-01-26 Merck & Co Inc Benzimidazole phosphate
US3127434A (en) * 1959-10-20 1964-03-31 Hoffmann La Roche Dihydrovitamin k monophosphate compounds and preparation thereof
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
JP2854631B2 (ja) * 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
US5114957A (en) * 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
AU3662093A (en) * 1992-02-14 1993-09-03 Robert Lamb Phosphate derivatives of vitamin e to protect cells from effects of aging and injury
JPH05286848A (ja) * 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd 浴用剤
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
AU7811094A (en) * 1993-11-27 1995-06-13 Knoll Aktiengesellschaft Compositions comprising iminium ion scavengers and/or nitrite scavengers
JP3362501B2 (ja) * 1994-04-28 2003-01-07 千寿製薬株式会社 角膜障害治療剤
JPH10155429A (ja) * 1996-11-27 1998-06-16 Showa Denko Kk 動物に対するビタミンｅ供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP4608031B2 (ja) * 1997-03-13 2011-01-05 ヘキサル アーゲー アミノ酸／シクロデキストリン混合物による酸感受性ベンズイミダゾール類の安定化
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
US6461623B2 (en) * 1998-04-13 2002-10-08 Kao Corporation Cosmetic composition
US6156354A (en) * 1999-01-29 2000-12-05 Brandeis University Hyper-absorption of vitamin E dispersed in milks
AU5594700A (en) * 1999-06-01 2000-12-18 Ocean Spray Cranberries, Inc. Cranberry seed oil extract and compositions containing components thereof
US6346544B2 (en) * 2000-03-02 2002-02-12 Oklahoma Medical Research Foundation Desmethyl tocopherols for protecting cardiovascular tissue
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP2269650A3 (en) * 2004-08-03 2012-05-16 Vital Health Sciences Pty Ltd. Carrier for enteral administration
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
NZ565049A (en) * 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos

Also Published As

Publication number Publication date
AUPR684801A0 (en) 2001-08-30
DE60219174D1 (de) 2007-05-10
US20090186856A1 (en) 2009-07-23
US20050009787A1 (en) 2005-01-13
EP1414470B1 (en) 2007-03-28
EP1414470A1 (en) 2004-05-06
CA2453884A1 (en) 2003-02-20
WO2003013550A1 (en) 2003-02-20
ES2284900T3 (es) 2007-11-16
ZA200400187B (en) 2004-10-12
JP2005506972A (ja) 2005-03-10
DE60219174T2 (de) 2007-12-27
ATE357919T1 (de) 2007-04-15
MXPA04000819A (es) 2004-06-03
EP1414470A4 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
BR0212013A (pt) Fosfatos micronutrientes como suplementos dietéticos ou para a saúde
BR0114080A (pt) Suplemento alimentìcio, uso do mesmo, método para auxiliar a prevenção ou tratamento de dano oxidativo, alimento, e, métodos para fabricar o mesmo, e para melhorar ou aumentar a produção de trabalho de um animal
DK1001685T3 (da) Næringsmiddelsammensætning indeholdende methionin
WO2004024079A8 (en) Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals
WO2003086267A3 (en) Multi-phase, multi-compartment capsular system
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
BR0016065A (pt) Composição nutricional
MY134881A (en) Improving condition of elderly pets
CA2332174A1 (en) Nutritional supplement based on blackcurrant seed oil
ATE361001T1 (de) Nahrungsmittel enthaltend vitamin k2
WO2003013270A3 (en) Calcium dietary supplement
Opara et al. Antioxidants and micronutrients
MXPA04001779A (es) Modulacion de almacenamiento de vitamina.
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
BR0212887A (pt) Método para aumentar nìveis de uma forma de armazenagem de uma vitamina e uso de uma quantidade eficaz de um derivado de fosfato de uma vitamina
DK1119363T3 (da) Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel
CA2468180A1 (en) Anti-proliferative composition
MXPA04003499A (es) Utilizacion de cistationina.
ATE173631T1 (de) Diätetische cholesterinsenkende zubereitungen, die sojaproteine und sitosterine enthalten
TR200401701T4 (tr) Zenginleştirilmiş besin ve terapötik etkinliğe sahip kreatin tuzu ve bunu içeren kompozisyonlar
WO2001091769A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2001091768A3 (en) Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2002098442A3 (de) Phytasehaltige zusammensetzung
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
ATE402708T1 (de) Diätergänzung für neuropatischen patienten

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.